Jennifer Pietenpol receives award from T.J. Martell Foundation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JENNIFER PIETENPOL was honored with the Medical Research Advancement Award during the T.J. Martell Foundation Nashville Honors Gala. Pietenpol is the B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center.

The award is in recognition of Pietenpol’s career as a cancer researcher. She focuses on the p53 family of proteins and breast cancer, especially triple-negative breast cancer.

Pietenpol joined the Vanderbilt faculty in 1994 and was named director of VICC in 2007. In addition, she has been named to the Institute of Medicine’s National Cancer Policy Forum and is a previous presidential appointee on the National Cancer Advisory Board.

Previously, Pietenpol has received the Burroughs Wellcome New Investigator Award, the Excellence in Teaching Award at Vanderbilt University and the Carleton College Distinguished Alumni Achievement Award. She was inducted into the Johns Hopkins Society of Scholars, and is an elected fellow of the American Association for the Advancement of Science, for work including advances in the understanding of signaling networks in breast and other cancers. She has authored or co-authored over 125 articles published in peer-reviewed scientific literature.

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login